Indoco Remedies Completes Transfer of Ophthalmic Division to Sunways (India) Private Limited
Indoco Remedies Limited has confirmed the completion of the business transfer of its Ophthalmic Division. The transfer to Sunways (India) Private Limited was finalized on May 18, 2026.The transaction pertains to the sale and transfer of the Company's ophthalmic business, covering the territories of India, Benin, Burkina Faso, Ivory Coast, Mali, Niger, Mauritania, Senegal, Cameroon, Congo, Gabon, Kenya, Botswana, Tanzania, Zambia, Zimbabwe, and Namibia.
The transfer was executed in line with the previously approved Agreement to Transfer Business (ATB). The sale was conducted on a slump sale basis, and the business is being transferred as a going concern.
Indoco Remedies Limited has reported that, with all conditions precedent fulfilled, the transfer of the Ophthalmic Division to Sunways (India) Private Limited was successfully completed on the specified date.
INDOCO Stock Price Movement
Shares of Indoco Remedies Limited on Monday slipped by 4.42% to close at ₹215.26. Trading saw a volume of 54,771 shares, as the stock struggled to hold above its ₹214.2 day low.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.